NCT02571036 2023-12-13A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced MalignanciesDeciphera Pharmaceuticals, LLCPhase 1 Completed282 enrolled
NCT00623831 2022-10-25A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 AntigenLudwig Institute for Cancer ResearchPhase 1 Completed17 enrolled 14 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts
NCT00049296 2010-06-11Thalidomide and Docetaxel in Treating Patients With Advanced CancerCase Comprehensive Cancer CenterPhase 1 Completed26 enrolled
NCT00041808 2005-06-24Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverFeRxPhase 1/2 Completed20 enrolled